Innovative Eyewear Inc Receivables Turnover Ratio (LUCY), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Innovative Eyewear Inc   (NASDAQ: LUCY)
 

Innovative Eyewear Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Innovative Eyewear Inc 's ability to collect accounts receivable sequentially worsen to 25.35, indicating more challenging environment then in the second quarter 2026, but still, it is a far cry from any concerns. Innovative Eyewear Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 14 days, from 12 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 38 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 279 to 426.

What is Receivable Turnover Ratio?
What is Innovative Eyewear Inc Selling?


What is Receivable Turnover Ratio?





LUCY Receivables Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Receivable Change 190.64 % 135.35 % -20.25 % 31.72 % 3.05 %
Y / Y Revenue Change 51.12 % 74.46 % 70.2 % 38.96 % 163.46 %
Receivable Turnover Ratio (TTM) 25.35 31.49 33.59 28.53 28.24
LUCY's Total Ranking # 426 # 279 # 2435 # 2365 #
Accounts Receivable average collection period days 14 12 11 13 13
Seq. Receivable Change 77.62 % 90.76 % -49.7 % 70.53 % 43.83 %
Seq. Revenue Change -0.08 % 30.63 % -19.4 % 43.66 % 15.35 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 10
Healthcare Sector # 39
Overall Market # 426

Receivable Turnover Ratio Statistics
High Average Low
33.59 17.01 3.71
(Mar 31 2026)   (Mar 31 2023)






Financial Statements
Innovative Eyewear Inc 's Accounts Receivable $ 0 Millions Visit LUCY's Balance sheet
Innovative Eyewear Inc 's Sales TTM $ 4 Millions Visit LUCY's Income Statement
Sources of LUCY's Revenues Visit LUCY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LUCY's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LUCY's Growth Rates LUCY's Roa LUCY's Inventory Turnover Ratio LUCY's Dividend Comparisons
LUCY's Profitability Ratios LUCY's Roi LUCY's Asset Turnover Ratio LUCY's Dividend Growth
LUCY's Valuation Ratios LUCY's Roe LUCY's Financial Strength Ratios LUCY's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Kiniksa Pharmaceuticals International Plc  40.65 $ 945.963  Millions$ 23.272  Millions
Innovage Holding Corp   34.59 $ 1,018.359  Millions$ 29.443  Millions
Fortrea Holdings Inc   29.58 $ 2,666.700  Millions$ 90.150  Millions
Sonida Senior Living Inc   27.65 $ 638.130  Millions$ 23.076  Millions
Wave Life Sciences Ltd   24.65 $ 87.296  Millions$ 3.541  Millions
Lenz Therapeutics Inc   24.39 $ 12.359  Millions$ 0.507  Millions
Arvinas Inc   20.06 $ 275.300  Millions$ 13.725  Millions
U S Physical Therapy Inc  18.16 $ 837.629  Millions$ 46.137  Millions
Alpha Pro Tech Ltd   17.54 $ 64.940  Millions$ 3.702  Millions
Biogen Inc   15.19 $ 10,297.300  Millions$ 677.900  Millions
Lifestance Health Group Inc   14.89 $ 1,676.889  Millions$ 112.631  Millions
Amneal Pharmaceuticals Inc   14.24 $ 3,196.184  Millions$ 224.488  Millions
Corcept Therapeutics Inc  13.44 $ 963.647  Millions$ 71.710  Millions
Precipio inc   13.38 $ 27.762  Millions$ 2.075  Millions
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Biodesix Inc   11.45 $ 105.212  Millions$ 9.192  Millions
Gossamer Bio Inc   11.37 $ 78.423  Millions$ 6.896  Millions
Icu Medical Inc  11.32 $ 2,183.556  Millions$ 192.845  Millions
Mannkind Corporation  10.97 $ 413.370  Millions$ 37.686  Millions
Lensar Inc   10.64 $ 60.079  Millions$ 5.645  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Voyager Therapeutics Inc   9.84 $ 25.108  Millions$ 2.551  Millions
Myomo Inc   9.66 $ 47.775  Millions$ 4.947  Millions
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Co diagnostics Inc   9.12 $ 0.859  Millions$ 0.094  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Lexicon Pharmaceuticals Inc   8.77 $ 38.537  Millions$ 4.396  Millions

Date modified: 2026-11-10T10:03:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.